US Stocks
/
Citius Pharmaceuticals, Inc. Share Price
Citius Pharmaceuticals, Inc. Share Price

Citius Pharmaceuticals, Inc. Share Price

NASDAQ: CTXR
$0.50
+$0.50 (--%) Last updated on 10 Oct, 2026 | 01:17 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Citius Pharmaceuticals, Inc. Stock Performance

Open
$0.49
Prev. Close
N/A
Circuit Range
N/A
Day Range
$0.49 - $0.50
Year Range
$0.48 - $2.15
Volume
295
Average Traded
$0.49

Citius Pharmaceuticals, Inc. Share Price Chart

$0.49$0.50
L
Show Current Price
H

Citius Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.69
Revenue (TTM)
$0.00
Return On Equity (TTM)
-69.47%
Profit Margin
N/A
Debt to Equity
0.10
Quarterly Earnings Growth YoY
-11.31%

Citius Pharmaceuticals, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$3.94$1.67$1.49
Net Profit-$7.96-$8.22-$21.23-$8.86
Net Profit MarginN/A-208.63%-1271.26%-594.63%
Income ChangeN/A-3.27%-158.27%58.27%

Citius Pharmaceuticals, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$33.64-$33.69-$40.19-$37.43
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-0.15%-19.29%6.87%

About Citius Pharmaceuticals, Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, with a focus on oncology, anti-infectives in adjunct cancer care and distinct prescription products. It aims to provide therapeutic products that address unmet medical needs yet have a lower development risk than is usually associated with new chemical entities. The company's flagship product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein. It operates through a single operating and reportable segment which is focused on developing and commercializing pioneering targeted oncology therapies.

Citius Pharmaceuticals, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$0.54
$0.50
-9.62%
Sep 2026
$0.58
$0.55
-10.26%
Aug 2026
$0.59
$0.61
+7.72%
Jul 2026
$0.62
$0.57
-2.40%
Jun 2026
$0.63
$0.58
-12.05%
May 2026
$0.69
$0.66
-3.07%
Apr 2026
$0.85
$0.69
-24.64%
Mar 2026
$0.72
$0.91
+24.01%
Feb 2026
$0.74
$0.73
-1.08%
Jan 2026
$0.79
$0.74
-3.14%
Dec 2025
$1.39
$0.77
-46.50%
Nov 2025
$1.58
$1.43
-8.33%

CTXR Share Price FAQs

What is Citius Pharmaceuticals, Inc. share price today?

chevron-up
Citius Pharmaceuticals, Inc. share price today is $0.50 as on October 10, 2026 at 1:17 am IST.

What is the 52 week high and 52 week low of Citius Pharmaceuticals, Inc. stock?

chevron-up
The 52 week high of Citius Pharmaceuticals, Inc. stock is $2.15, while the 52 week low is $0.48 as of 10 Oct '26.

What is CTXR's net income for the last quarter?

chevron-up
CTXR's net income for the last quarter is -8.86B USD.

What is the 5 year returns of CTXR?

chevron-up
The 5 year returns of CTXR is -98.93% as on 10 Oct '26.

What is the high & low stock price of CTXR today?

chevron-up
CTXR stock price hit a high of $0.50 and low of $0.49 as of 10 Oct '26.

Can I buy CTXR shares in India?

chevron-up
Yes. You can buy CTXR in India by opening an international trading account.